Sihuan Pharmaceutical Holdings Group (SHPHF) Ratios
Sihuan Pharmaceutical Holdings Group Ratios
SHPHF's free cash flow for Q2 2026 was $-136.97M. For the 2026 fiscal year, SHPHF's free cash flow was decreased by $-47.09M and operating cash flow was $-89.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.80 | 1.73 | 1.51 | 2.59 | 3.09 |
| Quick Ratio | 1.58 | 1.60 | 1.37 | 2.35 | 2.81 |
| Cash Ratio | 0.96 | 1.06 | 0.95 | 1.51 | 2.27 |
| Solvency Ratio | 0.09 | -0.01 | 0.03 | -0.24 | 0.13 |
| Operating Cash Flow Ratio | -0.01 | 0.07 | 0.05 | 0.02 | 0.27 |
| Short-Term Operating Cash Flow Coverage | -0.09 | 1.44 | 0.69 | 0.14 | 3.33 |
| Net Current Asset Value | $ 1.92B | $ 135.35M | $ -194.65M | $ 49.66M | $ 2.40B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.09 | 0.11 | 0.11 | 0.07 |
| Debt-to-Equity Ratio | 0.17 | 0.22 | 0.28 | 0.27 | 0.13 |
| Debt-to-Capital Ratio | 0.15 | 0.18 | 0.22 | 0.21 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.14 | 0.17 | 0.15 | 0.09 |
| Financial Leverage Ratio | 1.99 | 2.41 | 2.60 | 2.56 | 1.75 |
| Debt Service Coverage Ratio | 1.03 | -0.57 | 0.43 | -3.15 | 2.14 |
| Interest Coverage Ratio | 3.01 | -0.50 | 0.60 | -8.67 | 6.58 |
| Debt to Market Cap | 0.09 | 0.15 | 0.22 | 0.15 | 0.09 |
| Interest Debt Per Share | 0.13 | 0.13 | 0.16 | 0.16 | 0.13 |
| Net Debt to EBITDA | -3.64 | 12.36 | -7.88 | 1.65 | -4.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.83% | 65.32% | 69.64% | 68.20% | 79.99% |
| EBIT Margin | 18.21% | -20.48% | 5.81% | -87.64% | 22.26% |
| EBITDA Margin | 26.81% | -10.98% | 17.97% | -70.69% | 30.66% |
| Operating Profit Margin | 23.19% | -7.27% | 8.69% | -83.93% | 25.41% |
| Pretax Profit Margin | 15.93% | -22.53% | -8.67% | -97.32% | 16.32% |
| Net Profit Margin | 6.86% | -11.40% | -2.90% | -87.79% | 13.71% |
| Continuous Operations Profit Margin | 7.08% | -24.80% | -13.85% | -106.34% | 7.99% |
| Net Income Per EBT | 43.08% | 50.59% | 33.50% | 90.21% | 83.97% |
| EBT Per EBIT | 68.71% | 310.06% | -99.73% | 115.95% | 64.25% |
| Return on Assets (ROA) | 1.54% | -2.06% | -0.47% | -15.77% | 2.87% |
| Return on Equity (ROE) | 3.07% | -4.96% | -1.22% | -40.42% | 5.03% |
| Return on Capital Employed (ROCE) | 7.64% | -1.91% | 2.18% | -19.06% | 6.44% |
| Return on Invested Capital (ROIC) | 3.28% | -1.87% | 2.09% | -20.61% | 3.45% |
| Return on Tangible Assets | 1.68% | -2.18% | -0.50% | -16.59% | 2.97% |
| Earnings Yield | 1.78% | -3.77% | -0.99% | -24.47% | 3.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.52 | 3.20 | 4.68 | 4.18 | 3.90 |
| Payables Turnover | 2.10 | 2.73 | 2.56 | 3.37 | 5.11 |
| Inventory Turnover | 0.98 | 1.58 | 1.01 | 1.14 | 0.85 |
| Fixed Asset Turnover | 1.06 | 0.72 | 0.65 | 0.73 | 0.74 |
| Asset Turnover | 0.22 | 0.18 | 0.16 | 0.18 | 0.21 |
| Working Capital Turnover Ratio | 0.97 | 0.84 | 0.61 | 0.47 | 0.66 |
| Cash Conversion Cycle | 439.29 | 210.94 | 295.61 | 298.37 | 451.68 |
| Days of Sales Outstanding | 240.82 | 114.03 | 78.04 | 87.39 | 93.59 |
| Days of Inventory Outstanding | 371.94 | 230.82 | 360.11 | 319.27 | 429.48 |
| Days of Payables Outstanding | 173.47 | 133.92 | 142.55 | 108.29 | 71.39 |
| Operating Cycle | 612.76 | 344.85 | 438.15 | 406.66 | 523.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.03 | 0.02 | 0.00 | 0.07 |
| Free Cash Flow Per Share | -0.02 | 0.01 | -0.01 | -0.04 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | -0.08 | 0.67 | 0.34 | 0.03 | 0.92 |
| Capital Expenditure Coverage Ratio | -0.12 | 1.31 | 0.68 | 0.12 | 1.11 |
| Operating Cash Flow Coverage Ratio | -0.02 | 0.26 | 0.16 | 0.04 | 0.62 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.13 | 0.11 | 0.02 | 0.22 |
| Free Cash Flow Yield | -2.16% | 1.00% | -1.75% | -4.55% | 0.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 56.08 | -26.51 | -101.37 | -4.09 | 27.29 |
| Price-to-Sales (P/S) Ratio | 3.85 | 3.02 | 2.94 | 3.59 | 3.74 |
| Price-to-Book (P/B) Ratio | 1.72 | 1.31 | 1.24 | 1.65 | 1.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -46.22 | 99.87 | -57.08 | -21.99 | 176.86 |
| Price-to-Operating Cash Flow Ratio | -427.74 | 23.55 | 27.45 | 168.34 | 17.09 |
| Price-to-Earnings Growth (PEG) Ratio | -0.30 | -0.09 | 1.04 | 0.01 | -1.54 |
| Enterprise Value Multiple | 10.72 | -15.16 | 8.50 | -3.43 | 7.26 |
| Enterprise Value | 7.52B | 3.16B | 2.84B | 5.29B | 6.77B |
| EV to EBITDA | 10.72 | -15.16 | 8.50 | -3.43 | 7.26 |
| EV to Sales | 2.87 | 1.66 | 1.53 | 2.42 | 2.23 |
| EV to Free Cash Flow | -34.50 | 55.02 | -29.61 | -14.86 | 105.27 |
| EV to Operating Cash Flow | -319.35 | 12.97 | 14.24 | 113.75 | 10.17 |
| Tangible Book Value Per Share | 0.65 | 0.47 | 0.48 | 0.54 | 0.92 |
| Shareholders’ Equity Per Share | 0.64 | 0.47 | 0.48 | 0.51 | 0.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.56 | -0.10 | -0.60 | -0.09 | 0.51 |
| Revenue Per Share | 0.29 | 0.21 | 0.20 | 0.23 | 0.32 |
| Net Income Per Share | 0.02 | -0.02 | -0.01 | -0.21 | 0.04 |
| Tax Burden | 0.43 | 0.51 | 0.33 | 0.90 | 0.84 |
| Interest Burden | 0.88 | 1.10 | -1.49 | 1.11 | 0.73 |
| Research & Development to Revenue | 0.13 | 0.27 | 0.32 | 0.50 | 0.29 |
| SG&A to Revenue | 0.43 | 0.62 | 0.25 | 0.25 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.22 | 0.05 | 0.04 | 0.02 |
| Income Quality | -0.06 | -0.57 | -1.24 | -0.02 | 1.60 |
Currency in CNY
